Recruiting NA INTERVENTIONAL 1-arm
NCT07403630
INTEGRATIVE MULTI-OMICS AND FUNCTIONAL PLATFORM FOR THE COMPLETE DIAGNOSTIC CHARACTERIZATION OF TUMORS: THE ITALIAN TUMOR CHEMOGENOMIC PROFILER (IT-TCP) (IT-TCP POS)
Sponsor: Azienda Ospedaliero-Universitaria di Parma
Conditions
Acute Leukemia Bladder Cancer Chronic Leukemia Melanoma Multiple Myeloma Myelodysplastic Disorders Myeloproliferative Disorders Ovarian Cancer Pancreatic Cancer Pediatric Acute Lymphoblastic Leukemia Pleural Mesothelioma Squamous Cell Carcinoma
Interventions
Cytogenetics/ FISH Functional tests Multi-omics analyses
Updated 1 time since 2026 Last updated: Feb 13, 2026 Started: May 31, 2023 Primary completion: Feb 28, 2027 Completion: Feb 12, 2028
This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.
Listed as NCT07403630, this NA trial focuses on Acute Leukemia and Bladder Cancer and remains actively recruiting participants. Sponsored by Azienda Ospedaliero-Universitaria di Parma, it has been updated 1 time since 2023, reflecting limited change activity. This study contributes to the evolving evidence base for cancer treatment protocols.
Status Flow
Change History
1 version recorded Recruiting — NA
[monthly]
Eligibility Summary
No eligibility information available.
Contact Information
Sponsor contact:
- Azienda Ospedaliero-Universitaria di Parma
Data source: Azienda Ospedaliero-Universitaria di Parma
For direct contact, visit the study record on ClinicalTrials.gov .